ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026
FDA Approval Summary: Erdafitinib for FGFR3-Altered Locally Advanced or Metastatic Urothelial Carcinoma.
William F Maguire et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.